0
0
36 words
0
Comments
"The observations will be responded to within the stipulated time. The plant is yet to start commercial operations," Aurobindo Pharma said.
You are the first to view
https://www.moneycontrol.com/news/business/usfda-inspects-aurobindo-pharmas-new-jersey-based-facility-issues-10-observations-11950681.html
Create an account or login to join the discussion